Q2 2024 EPS Estimates for AdaptHealth Corp. (NASDAQ:AHCO) Decreased by Analyst

AdaptHealth Corp. (NASDAQ:AHCO - Free Report) - Equities research analysts at Leerink Partnrs reduced their Q2 2024 earnings per share estimates for AdaptHealth in a research report issued on Wednesday, May 22nd. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $0.21 for the quarter, down from their prior estimate of $0.24. The consensus estimate for AdaptHealth's current full-year earnings is $0.78 per share. Leerink Partnrs also issued estimates for AdaptHealth's Q4 2024 earnings at $0.44 EPS, FY2024 earnings at $0.88 EPS, Q1 2025 earnings at $0.15 EPS and FY2025 earnings at $1.01 EPS.

AHCO has been the subject of several other research reports. UBS Group raised their price target on shares of AdaptHealth from $9.00 to $13.00 and gave the stock a "buy" rating in a research note on Wednesday, February 28th. Truist Financial reaffirmed a "buy" rating and set a $13.00 price target on shares of AdaptHealth in a research report on Wednesday, May 15th. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $13.00 price objective on shares of AdaptHealth in a report on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $12.42.

AdaptHealth Stock Performance

AHCO stock traded up $0.45 during mid-day trading on Monday, hitting $10.07. The company had a trading volume of 665,100 shares, compared to its average volume of 1,080,315. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.11 and a current ratio of 1.33. The firm has a market cap of $1.34 billion, a PE ratio of -1.91, a price-to-earnings-growth ratio of 0.73 and a beta of 1.06. AdaptHealth has a 12 month low of $6.37 and a 12 month high of $15.37. The stock's fifty day moving average price is $10.18 and its two-hundred day moving average price is $8.80.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last released its earnings results on Tuesday, May 7th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.04). The business had revenue of $792.50 million for the quarter, compared to the consensus estimate of $771.08 million. AdaptHealth had a positive return on equity of 8.47% and a negative net margin of 21.45%.

Insider Transactions at AdaptHealth

In related news, major shareholder James E. Flynn sold 182,607 shares of the business's stock in a transaction on Monday, March 11th. The stock was sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the sale, the insider now directly owns 11,643,769 shares in the company, valued at approximately $128,314,334.38. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, major shareholder James E. Flynn sold 182,607 shares of the business's stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the completion of the transaction, the insider now owns 11,643,769 shares of the company's stock, valued at $128,314,334.38. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder James E. Flynn sold 52,487 shares of the firm's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $10.93, for a total transaction of $573,682.91. Following the completion of the transaction, the insider now directly owns 11,826,376 shares of the company's stock, valued at $129,262,289.68. The disclosure for this sale can be found here. Corporate insiders own 4.43% of the company's stock.

Institutional Trading of AdaptHealth

Several institutional investors and hedge funds have recently modified their holdings of AHCO. Texas Permanent School Fund Corp increased its position in shares of AdaptHealth by 1.4% in the first quarter. Texas Permanent School Fund Corp now owns 71,201 shares of the company's stock worth $820,000 after purchasing an additional 979 shares during the last quarter. ProShare Advisors LLC increased its holdings in shares of AdaptHealth by 7.6% in the 1st quarter. ProShare Advisors LLC now owns 18,994 shares of the company's stock worth $219,000 after buying an additional 1,338 shares during the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of AdaptHealth by 6.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 24,504 shares of the company's stock worth $179,000 after buying an additional 1,382 shares during the last quarter. SummerHaven Investment Management LLC raised its position in shares of AdaptHealth by 2.6% during the 4th quarter. SummerHaven Investment Management LLC now owns 54,754 shares of the company's stock valued at $399,000 after buying an additional 1,411 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of AdaptHealth by 197.1% during the 1st quarter. GAMMA Investing LLC now owns 2,537 shares of the company's stock worth $29,000 after acquiring an additional 1,683 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.